CADL
USDCandel Therapeutics Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$5.030
最高
$5.270
最低
$5.030
交易量
0.50M
公司基本面
市值
281.6M
行業
生物科技
國家
United States
交易統計
平均交易量
0.77M
交易所
NGM
貨幣
USD
52週範圍
相關新聞
Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors
Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., FMedSci, Candel's President and CEO, will present the phase 3 clinical trial of
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London
NEEDHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies
Stephens & Co. Initiates Coverage On Candel Therapeutics with Overweight Rating, Announces Price Target of $15
Stephens & Co. analyst Sudan Loganathan initiates coverage on Candel Therapeutics with a Overweight rating and announces Price Target of $15.
LifeSci Capital Initiates Coverage On Candel Therapeutics with Outperform Rating, Announces Price Target of $16
LifeSci Capital initiates coverage on Candel Therapeutics with a Outperform rating and announces Price Target of $16.
